Biogen BIIB
NASDAQ BIIB
$216.78 +2.43 (+1.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biogen (BIIB) Prepaid Assets (2009 - 2026)

Biogen (BIIB) posted quarterly Prepaid Assets of $1.2 billion for Q2 2026, up 45.54% year-over-year from $850.6 million in Q2 2025, and up 5.97% quarter-over-quarter from $1.2 billion in Q1 2026.

Biogen (BIIB) Prepaid Assets (2009 - 2026) Analysis & Trends

Biogen's Prepaid Assets history runs 18 years deep, the most recent figure standing at $1.2 billion for Q2 2026.

  • In Q2 2026, Prepaid Assets rose 45.54% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (up 45.54% YoY), while the FY2025 annual figure was $1.1 billion, up 49.28% from the prior year.
  • Prepaid Assets for Q2 2026 stood at $1.2 billion, up from $1.2 billion in the prior quarter.
  • The five-year high for Prepaid Assets was $1.6 billion in Q2 2022, with the low at $615.3 million in Q2 2024.
  • The 5-year median for Prepaid Assets is $1.0 billion (2023), against an average of $1.1 billion.
  • The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 114.26% in 2022, then plunged 45.55% in 2023.
  • Biogen's Prepaid Assets stood at $1.4 billion in 2022, then retreated by 16.62% to $1.2 billion in 2023, then plunged by 36.34% to $752.5 million in 2024, then jumped by 49.28% to $1.1 billion in 2025, then climbed by 10.21% to $1.2 billion in 2026.
  • Business Quant data shows BIIB's Prepaid Assets at $1.2 billion in Q2 2026, $1.2 billion in Q1 2026, and $1.1 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Biogen 32.04 Bn 30.76 Bn 1.96 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.24 Bn
Mar 31, 2026 1.17 Bn
Dec 31, 2025 1.12 Bn
Sep 30, 2025 916.80 Mn
Jun 30, 2025 850.60 Mn
Mar 31, 2025 757.30 Mn
Dec 31, 2024 752.50 Mn
Sep 30, 2024 674.00 Mn
Jun 30, 2024 615.30 Mn
Mar 31, 2024 1.17 Bn
Dec 31, 2023 1.18 Bn
Sep 30, 2023 974.10 Mn
Jun 30, 2023 895.90 Mn
Mar 31, 2023 1.41 Bn
Dec 31, 2022 1.42 Bn
Sep 30, 2022 1.50 Bn
Jun 30, 2022 1.65 Bn
Mar 31, 2022 927.40 Mn
Dec 31, 2021 740.80 Mn
Sep 30, 2021 736.30 Mn